---
figid: PMC6157710__emss-79529-f001
figtitle: Directing the use of DDR kinase inhibitors in cancer treatment
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Danio rerio
pmcid: PMC6157710
filename: emss-79529-f001.jpg
figlink: /pmc/articles/PMC6157710/figure/F1/
number: F1
caption: 'A) Ataxia-telangiectasia mutated (ATM) is recruited to and activated at
  DNA Double Strand Breaks (DSBs). Once activated, ATM phosphorylates p53 and CHK2,
  resulting in a G1/S cell cycle arrest via CDC25A and Cyclin-CDK (Cyclin-dependent
  kinase) complexes. Ataxia-telangiectasia and Rad3-related (ATR) is activated at
  persistent stretches of single strand DNA (ssDNA) coated by Replication Protein
  A (RPA); such ssDNA stretches occur at sites of resection or stalled replication
  forks. ATR primarily activates CHK1. CHK1 can signal via CDC25A to activate the
  intra S checkpoint or via CDC25A and WEE1 to activate the G2/M checkpoint, depending
  on the phase of the cell cycle the damage is detected in. DNA dependent protein
  kinase (DNA-PK), activated at DSBs, does not play a role in the regulation of cell
  cycle progression after DNA damage. Kinases discussed in this review are highlighted
  in red. Dashed arrows indicate indirect regulation. B) Candidate predictive biomarkers
  for ATM, ATR, DNA-PK, CHK1 and WEE1 discussed in this review. ALT: Alternative lengthening
  of telomeres.'
papertitle: Directing the use of DDR kinase inhibitors in cancer treatment.
reftext: Inger Brandsma, et al. Expert Opin Investig Drugs. 2017 Dec;26(12):1341-1355.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.924946
figid_alias: PMC6157710__F1
figtype: Figure
redirect_from: /figures/PMC6157710__F1
ndex: 615bd32e-deeb-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6157710__emss-79529-f001.html
  '@type': Dataset
  description: 'A) Ataxia-telangiectasia mutated (ATM) is recruited to and activated
    at DNA Double Strand Breaks (DSBs). Once activated, ATM phosphorylates p53 and
    CHK2, resulting in a G1/S cell cycle arrest via CDC25A and Cyclin-CDK (Cyclin-dependent
    kinase) complexes. Ataxia-telangiectasia and Rad3-related (ATR) is activated at
    persistent stretches of single strand DNA (ssDNA) coated by Replication Protein
    A (RPA); such ssDNA stretches occur at sites of resection or stalled replication
    forks. ATR primarily activates CHK1. CHK1 can signal via CDC25A to activate the
    intra S checkpoint or via CDC25A and WEE1 to activate the G2/M checkpoint, depending
    on the phase of the cell cycle the damage is detected in. DNA dependent protein
    kinase (DNA-PK), activated at DSBs, does not play a role in the regulation of
    cell cycle progression after DNA damage. Kinases discussed in this review are
    highlighted in red. Dashed arrows indicate indirect regulation. B) Candidate predictive
    biomarkers for ATM, ATR, DNA-PK, CHK1 and WEE1 discussed in this review. ALT:
    Alternative lengthening of telomeres.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - POLD1
  - ARID1A
  - SETD2
  - ERCC1
  - SMO
  - SMOX
  - TOPBP1
  - ERCC4
  - CDK9
  - KDM6A
  - GPT
  - RAD17
  - AKT1
  - AKT2
  - AKT3
  - VHL
  - MTOR
  - RPA1
  - RPA2
  - RPA3
  - FCGR1A
  - FCGR1BP
  - FCGR1CP
  - ATRIP
  - PRKDC
  - ATM
  - ATR
  - ANTXR1
  - MMAB
  - SERPINA2
  - CDK4
  - TP53
  - TP63
  - TP73
  - CHEK2
  - CHEK1
  - CDK1
  - WEE1
  - CDC25A
  - CDC25C
  - CDK6
  - CDK2
  - CCND1
  - CCNE1
  - CCNE2
  - CCNB1
  - CCNB2
  - CCNB3
  - WARS1
  - Pold1
  - Arid1a
  - Setd2
  - Ercc1
  - Smo
  - Smox
  - Topbp1
  - Ercc4
  - Cdk9
  - Kdm6a
  - Gpt
  - Rad17
  - Akt1
  - Mtor
  - Rpa1
  - Atrip
  - Prkdc
  - Atm
  - Tpm1
  - Atr
  - Mmab
  - Cdk4
  - Trp53
  - Chek2
  - Chek1
  - Cdk1
  - Wee1
  - Cdc25a
  - Cdc25c
  - Cdk6
  - Cdk2
  - Ccnd1
  - Gabrg2
  - Uty
  - Igf1r
  - Defb1
  - Tp53
  - Ldha
  - pold1
  - setd2
  - ercc1
  - smo
  - topbp1
  - cdk9
  - kdm6a
  - rad17
  - mtor
  - rpa2
  - atrip
  - atm
  - atr
  - cdk4
  - tp53
  - cdk1
  - wee1
  - cdc25b
  - cdk6
  - cdk2
  - ccnd1
  - Cancer
---
